Tema Cardiovascular and Metabolic ETF
Limited financial coverage for HRTS.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries. Its investment mandate specifically targets firms focused on advancing treatments and therapies for cardiovascular health, metabolic disorders, and weight management.
- IPO
- 2023
- HQ
- New York, NY, US
Price Chart
- Market Cap
- $51.75M
- Div Yield
- 1.27%
- 52W High
- $37.27
- 52W Low
- $27.23
- 50D MA
- $34.17
- 200D MA
- $34.15
- Beta
- 0.65
- Avg Volume
- 5.39K
Get TickerSpark's AI analysis on HRTS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our HRTS coverage
Recent articles, reports, and earnings notes.
No research on HRTS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HRTS report →Similar companies
Peers in the same neighborhood.